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The  early  pathophysiologic  study  showed  increasing  evidence 
that autoimmunity is implicated in the pathogenesis of neuro-
myotonia. Antibodies to voltage gated potassium channel were 
detected in the serum of patients who had peripheral nerves hy-
perexcitability and also Morvan’s disease or limbic encephalitis. 
These discoveries offered new approaches to treatments.
Recently, antibodies previously attributed to VGKC recognise 
2 surface antigens LGI1 and CASPR2 into the VGKC complex. 
Finally, VGKC antibodies are directed to 2 proteins the first one 
is a key hippocampic protein containing pre and post synaptic 
proteins. The second one CASPR2 is an hippocampic and par-
anodal protein. 
There clinical significance is different: hyperexcitability, limbic 
encephalitis without thymoma for LGI1, hyperexcitability, Mor-
van limbic encephalitis and frequent thymoma for CASPR2.
In conclusion, the term NMT - LE - VGKC should be changed 
to NMT- LE with LGI1 and CASPR2 antibodies and classified 
as auto immune synaptic disorders. Mutations in genes encoding 
both these proteins are found in hereditary epilepsy and other 
syndromes. Various potassium channelopathies are closely linked 
to Morvan’s syndromes. A new classification of antibodies will be 
necessary.
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Continuous muscle activity or Isaac’s syndrome (1) 
or neuromyotonia (a misnamed disorder because of the 
lack of myotonia) are one of a family of disorders char-
acterized  by  peripheral  nerves  hyperexcitability.  The 
earliest clinical description (2) gathers five patients with 
“la chorée fibrillaire”. All of them had muscle quiver-
ing  characteristic  of  neuromyotonia.  In  Morvan’s  syn-
drome, symptoms of neuromyotonia are associated with 
autonomic and central nervous system dysfunction with 
frequent insomnia (3, 4).These cases are close to limbic 
encephalitis  (with  short  memory  disturbances,  confu-
sion, seizures, personality changes, hyponatremia, hyp-
pocampal abnormalities on brain MRI) (5, 6). Both neu-
romyotonia and Morvan’s syndrome can be associated 
with tumours, particularly thymomas or with dysimmune 
disease (myasthenia gravis). For these reasons and taking 
into consideration the improvement with anti dysimmune 
therapy, the following hypothesis was suggested (7). An-
tibodies anti potassium voltage dependant (VGKC) could 
lead to a depolarization and muscle hyperactivity.
VGKC  antibodies  were  detected  by  immunopre-
cipitation of iodinated α-dendrotoxin (125 I α DTX) in 
brain homogenates. The VGKC antibody titers are higher 
(≥ pM) compared to controls (< 100 pM), mainly to KV1.1 
subunits. In addition to the previous syndrome VGKC an-
tibodies have also been identified (8) in epilepsies, type 1 
primary episodic ataxia (9) long QT syndrome, paroxys-
mal dystonia, Shaker group, and others (10).
However most VGKC antibodies don’t bind directly 
to KV1.1 subunits and it was recognized that VGKCs 
are not the targets for the VGKC antibodies (11) and the 
question was: are these syndromes due to antiVGKC an-
tibodies (K+ ionic channelopathy) or to anti non ionic 
secreted protein antibodies (12). Thus “the term limbic 
encephalitis”  – VGKC  should  be  changed  to  LE  with 
LGI1 antibodies and classified as autoimmune synaptic 
encephalopathy” (12).
In  fact,  most  VGKC-antibodies  bind  to  associate 
VGKC complex proteins. This complex gathers 2 target 
proteins: 
1. LGI1 (Leucin-rich Glioma Inactived 1), key hip-
pocampic protein of synaptic organisation with a large 
extra cellular sequence and multiple domains (13), associ-
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ated with KV1.1 subunits, connecting pre (Adam23) and 
post (Adam22) synaptic proteins forming a bridge (14)
2.  CASPR2  (Contactin  Associated  Protein2)  hip-
pocampic and paranodal (Ranvier node) membrane pro-
tein (15).
Mutations in genes encoding both these proteins are 
found in hereditary epilepsia and other syndromes (16). 
These mutations reflect the fact that genetic and autoim-
mune conditions often target the same proteins (11).
Interest  in  Morvan’s  disease  or  syndromes  has 
grown, owing to its close links with various potassium 
channelopathies and now disorders classified as autoim-
mune synaptic syndromes. Many new antibodies against 
neuronal cell surface antigens will probably be described 
in the future (17). A new classification of antibodies will 
certainly be necessary.
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